Figure 3 | Scientific Reports

Figure 3

From: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption

Figure 3

Coagulation and fibrinolysis factors of interest in the control, AFE, and sPA groups. We evaluated (a) tissue factor (TF), (b) tissue plasminogen activator (tPA), (c) annexin A2 (AnnA2), (d) total thrombin activatable fibrinolysis inhibitor (total TAFI, which included TAFI and TAFIa), and (e) plasminogen activator inhibitor-type 1 (PAI-1). The AFE group had significantly increased plasma levels of tPA and decreased total TAFI. AnnA2 levels were significantly higher in sPA than AFE patients; however, there were two fatal cases with the high levels of AnnA2 in the AFE group.

Back to article page